1. Home
  2. Labeler Index
  3. Eugia Us Llc
  4. 55150-252
  5. Product Images: Lidocaine Hydrochloride

Product Images Lidocaine Hydrochloride

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 100 mg per 10 mL (10 mg/mL) - 10 mL Container Label - lidocaine fig1
  2. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 100 mg per 10 mL (10 mg/mL) - 10 mL Container-Carton [25 Vials] - lidocaine fig2
  3. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 200 mg per 20 mL (10 mg/mL) - 20 mL Container Label - lidocaine fig3
  4. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 200 mg per 20 mL (10 mg/mL) - 20 mL Container-Carton [25 Vials] - lidocaine fig4
  5. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 200 mg per 10 mL (20 mg/mL) - 10 mL Container Label - lidocaine fig5
  6. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 200 mg per 10 mL (20 mg/mL) - 10 mL Container-Carton [25 Vials] - lidocaine fig6
  7. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 400 mg per 20 mL (20 mg/mL) - 20 mL Container Label - lidocaine fig7
  8. PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 400 mg per 20 mL (20 mg/mL) - 20 mL Container-Carton [25 Vials] - lidocaine fig8
  9. chemical-structure - lidocaine str

Product Label Images

The following 9 images provide visual information about the product associated with Lidocaine Hydrochloride NDC 55150-252 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 100 mg per 10 mL (10 mg/mL) - 10 mL Container Label - lidocaine fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 100 mg per 10 mL (10 mg/mL) - 10 mL Container Label - lidocaine fig1

This product is a sterile, nonpyrogenic solution containing Methylparaben as a preservative. It can be resterilized by autoclaving and should not be used if the solution is discolored or contains a precipitate. It is recommended to store the product at 20° to 25°C (68° to 77°F). The item is manufactured in India for Eugia US LLC in E. Windsor, NJ. The solution is intended for Infiltration and Nerve Block use only and is not suitable for Caudal or Epidural procedures. Each vial contains 100 mg per 10 mL and is a 2% solution (10 mg/mL).*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 100 mg per 10 mL (10 mg/mL) - 10 mL Container-Carton [25 Vials] - lidocaine fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 100 mg per 10 mL (10 mg/mL) - 10 mL Container-Carton [25 Vials] - lidocaine fig2

This is a detailed description of Lidocaine NDC 55150-251-24 1 % HCI Injection, USP used for infiltration and nerve block. It contains Lidocaine hydrochloride USP 10 mg per mL with sodium chloride, methylparaben as a preservative, and pH adjusting agents. The product is sterile, nonpyrogenic, and comes in a package of 25 vials of 10 mL each. It is not for caudal or epidural use and can be resterilized by autoclaving if needed. The vial stopper is latex-free, and the product is distributed by Eugia US LLC and is made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 200 mg per 20 mL (10 mg/mL) - 20 mL Container Label - lidocaine fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 200 mg per 20 mL (10 mg/mL) - 20 mL Container Label - lidocaine fig3

This text is product information for a pharmaceutical product called Eugie. It is a sterile, nonpyrogenic solution containing Methylparaben as a preservative, and it can be resterilized by autoclaving. The product is indicated for infiltration and nerve block but should not be used for caudal or epidural use. Each vial contains 200mg per 20mL and should be stored at 20° to 25°C. The manufacturer is Eugia US LLC located in E. Windsor, NJ.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 200 mg per 20 mL (10 mg/mL) - 20 mL Container-Carton [25 Vials] - lidocaine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1% 200 mg per 20 mL (10 mg/mL) - 20 mL Container-Carton [25 Vials] - lidocaine fig4

This is the essential description of a medical product that contains information about Lidocaine hydrochloride injections. The text mentions details such as the concentration of Lidocaine, other ingredients present in the injection, the recommended dosage, and instructions for use. Additionally, it states that the product is meant for infiltration and nerve block purposes but should not be used for caudal or epidural procedures. It also provides storage instructions, dosage information, and details of the manufacturer, including the fact that it is made in India. Overall, it is useful information for healthcare professionals or individuals using this specific medication.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 200 mg per 10 mL (20 mg/mL) - 10 mL Container Label - lidocaine fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 200 mg per 10 mL (20 mg/mL) - 10 mL Container Label - lidocaine fig5

This is a description of Lidocaine HCl Injection, USP containing 200mg per 10mL (20mg/mL). It is indicated for Infiltration and Nerve Block procedures but not for Caudal or Epidural use. The solution includes Methylparaben as a preservative and can be resterilized by autoclaving. The product should not be used if the solution is discolored or contains a precipitate. It is a 10mL Multiple-Dose Vial that is sterile and nonpyrogenic. The storage temperature recommended is 20° to 25°C (68° to 77°F). This product was manufactured in India for Eugia US LLC in E. Windsor, NJ 08520.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 200 mg per 10 mL (20 mg/mL) - 10 mL Container-Carton [25 Vials] - lidocaine fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 200 mg per 10 mL (20 mg/mL) - 10 mL Container-Carton [25 Vials] - lidocaine fig6

This is a medication label for Lidocaine HCI Injection, containing 200 mg per 10 mL. It provides information on dosage, pH adjustment, sterility, storage, and usage instructions like for Infiltration and Nerve Block. The label warns against Caudal or Epidural Use if the solution is discolored or contains a precipitate. It includes details about the preservatives used and the manufacturer.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 400 mg per 20 mL (20 mg/mL) - 20 mL Container Label - lidocaine fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 400 mg per 20 mL (20 mg/mL) - 20 mL Container Label - lidocaine fig7

This text appears to be a description of a medical product. It is a sterile, nonpyrogenic solution containing Lidocaine 2% (400 mg per 20 mL) for infiltration and nerve block procedures. The product is recommended for use as specified, not for caudal or epidural administration. Store at 20°to 25°C (68° to 77°F). NDC 55150-255-24. It is advised not to use if the solution is discolored or contains a precipitate.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 400 mg per 20 mL (20 mg/mL) - 20 mL Container-Carton [25 Vials] - lidocaine fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2% 400 mg per 20 mL (20 mg/mL) - 20 mL Container-Carton [25 Vials] - lidocaine fig8

This is a description of a pharmaceutical product contained in a 25x20 mL multiple-dose vial. The product contains Lidocaine hydrochloride USP and other ingredients, totaling 400 mg per 20 mL. It is sterile, nonpyrogenic, and the vial stopper is not made with natural rubber latex. The product is recommended for infiltration and nerve block procedures and can be resterilized by autoclaving. It should not be used for caudal or epidural purposes, and users are advised not to use if the solution is discolored or contains a precipitate. Methylparaben is used as a preservative, and it should be stored at 20° to 25°C.*

chemical-structure - lidocaine str

chemical-structure - lidocaine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.